JP2022526604A5 - - Google Patents
Info
- Publication number
- JP2022526604A5 JP2022526604A5 JP2021559255A JP2021559255A JP2022526604A5 JP 2022526604 A5 JP2022526604 A5 JP 2022526604A5 JP 2021559255 A JP2021559255 A JP 2021559255A JP 2021559255 A JP2021559255 A JP 2021559255A JP 2022526604 A5 JP2022526604 A5 JP 2022526604A5
- Authority
- JP
- Japan
- Prior art keywords
- product according
- pharmaceutical product
- alkyl
- cr9r9
- substituted
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962829923P | 2019-04-05 | 2019-04-05 | |
| US62/829,923 | 2019-04-05 | ||
| PCT/US2020/026639 WO2020206299A1 (en) | 2019-04-05 | 2020-04-03 | Selective inhibitors of protein arginine methyltransferase 5 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022526604A JP2022526604A (ja) | 2022-05-25 |
| JP2022526604A5 true JP2022526604A5 (enExample) | 2023-04-07 |
Family
ID=72667388
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021559255A Pending JP2022526604A (ja) | 2019-04-05 | 2020-04-03 | タンパク質アルギニンメチルトランスフェラーゼ５の選択的阻害剤 |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US12440506B2 (enExample) |
| EP (1) | EP3946352B1 (enExample) |
| JP (1) | JP2022526604A (enExample) |
| WO (1) | WO2020206299A1 (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11077101B1 (en) | 2018-07-18 | 2021-08-03 | Tango Therapeutics, Inc. | Compounds and methods of use |
| US12403137B2 (en) | 2019-10-28 | 2025-09-02 | Tango Therapeutics, Inc. | Compounds and methods of use |
| CN116568677B (zh) | 2020-07-31 | 2026-07-28 | 探戈医药股份有限公司 | 可用于治疗mtap缺乏和/或mta累积癌症的哌啶-1-基-n-吡啶-3-基-2-氧代乙酰胺衍生物 |
| CN113234079B (zh) * | 2021-04-30 | 2022-02-01 | 上海湃隆生物科技有限公司 | 用作prmt5抑制剂的核苷类似物 |
| CN113546173B (zh) * | 2021-08-19 | 2022-08-23 | 徐州医科大学 | Prmt5抑制剂在制备治疗冠状病毒感染所引起的疾病的药物中的应用 |
| WO2024170488A1 (en) | 2023-02-13 | 2024-08-22 | Astrazeneca Ab | Prmt5 inhibitor for use in cancer therapy |
| WO2024238628A1 (en) * | 2023-05-15 | 2024-11-21 | Prelude Therapeutics Incorporated | Treatment of recurrent high-grade glioma or uveal melanoma (um) using a brain-penetrant protein arginine methyltransferase 5 (prmt5) inhibitor |
Family Cites Families (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3657744A (en) | 1970-05-08 | 1972-04-25 | Univ Minnesota | Method for fixing prosthetic implants in a living body |
| US4733665C2 (en) | 1985-11-07 | 2002-01-29 | Expandable Grafts Partnership | Expandable intraluminal graft and method and apparatus for implanting an expandable intraluminal graft |
| US5023252A (en) | 1985-12-04 | 1991-06-11 | Conrex Pharmaceutical Corporation | Transdermal and trans-membrane delivery of drugs |
| US5040548A (en) | 1989-06-01 | 1991-08-20 | Yock Paul G | Angioplasty mehtod |
| US5350395A (en) | 1986-04-15 | 1994-09-27 | Yock Paul G | Angioplasty apparatus facilitating rapid exchanges |
| US5061273A (en) | 1989-06-01 | 1991-10-29 | Yock Paul G | Angioplasty apparatus facilitating rapid exchanges |
| US4748982A (en) | 1987-01-06 | 1988-06-07 | Advanced Cardiovascular Systems, Inc. | Reinforced balloon dilatation catheter with slitted exchange sleeve and method |
| US4992445A (en) | 1987-06-12 | 1991-02-12 | American Cyanamid Co. | Transdermal delivery of pharmaceuticals |
| US5001139A (en) | 1987-06-12 | 1991-03-19 | American Cyanamid Company | Enchancers for the transdermal flux of nivadipine |
| CA1322628C (en) | 1988-10-04 | 1993-10-05 | Richard A. Schatz | Expandable intraluminal graft |
| US5674278A (en) | 1989-08-24 | 1997-10-07 | Arterial Vascular Engineering, Inc. | Endovascular support device |
| US6344053B1 (en) | 1993-12-22 | 2002-02-05 | Medtronic Ave, Inc. | Endovascular support device and method |
| US5292331A (en) | 1989-08-24 | 1994-03-08 | Applied Vascular Engineering, Inc. | Endovascular support device |
| HRP20090646T1 (hr) | 2005-03-17 | 2010-01-31 | Proyecto De Biomedicina Cima | Uporaba 5'-metiltioadenozina (mta) kod prevencije i/ili liječenja autoimunih bolesti i/ili odbacivanje transplantata |
| WO2015200680A2 (en) | 2014-06-25 | 2015-12-30 | Epizyme, Inc. | Prmt5 inhibitors and uses thereof |
| EA031895B1 (ru) | 2015-02-24 | 2019-03-29 | Пфайзер Инк. | Замещенные нуклеозидные производные, полезные в качестве агентов против рака |
| AR104326A1 (es) | 2015-05-04 | 2017-07-12 | Lilly Co Eli | Compuestos nucleósidos 5-sustituidos |
| TWI730980B (zh) * | 2015-08-26 | 2021-06-21 | 比利時商健生藥品公司 | 使用作為ｐｒｍｔ５抑制劑之新穎經６-６雙環芳香環取代之核苷類似物 |
| CN108884108B (zh) | 2016-03-10 | 2021-08-31 | 詹森药业有限公司 | 用于用作prmt5抑制剂的取代核苷类似物 |
| WO2017218802A1 (en) | 2016-06-15 | 2017-12-21 | Prelude Therapeutics, Incorporated | Selective inhibitors of protein arginine methyltransferase 5 (prmt5) |
| WO2018065365A1 (en) | 2016-10-03 | 2018-04-12 | Janssen Pharmaceutica Nv | Novel monocyclic and bicyclic ring system substituted carbanucleoside analogues for use as prmt5 inhibitors |
| WO2018075601A1 (en) | 2016-10-18 | 2018-04-26 | Prelude Therapeutics, Incorporated | Selective inhibitors of protein arginine methyltransferase 5 (prmt5) |
| CN110325188A (zh) * | 2016-10-26 | 2019-10-11 | 印第安纳大学理事会 | 小分子蛋白质精氨酸甲基转移酶5(prmt5)抑制剂和治疗方法 |
| WO2018085833A2 (en) | 2016-11-07 | 2018-05-11 | Prelude Therapeutics, Incorporated | Selective inhibitors of protein arginine methyl transferase 5 (prmt5) |
| WO2018085818A1 (en) | 2016-11-07 | 2018-05-11 | Prelude Therapeutics, Incorporated | Selective inhibitors of protein arginine methyltransferase 5 (prmt5) |
| WO2018152548A1 (en) | 2017-02-20 | 2018-08-23 | Prelude Therapeutics, Incorporated | Selective inhibitors of protein arginine methyltransferase 5 (prmt5) |
| WO2018152501A1 (en) | 2017-02-20 | 2018-08-23 | Prelude Therapeutics, Incorporated | Selective inhibitors of protein arginine methyltransferase 5 (prmt5) |
| WO2018160824A1 (en) | 2017-03-01 | 2018-09-07 | Prelude Therapeutics, Incorporated | Selective inhibitors of protein arginine methyltransferase 5 (prmt5) |
| WO2018160855A1 (en) | 2017-03-01 | 2018-09-07 | Prelude Therapeutics, Incorporated | Selective inhibitors of protein arginine methyltransferase 5 (prmt5) |
| MA49840A (fr) * | 2017-08-09 | 2020-06-17 | Prelude Therapeutics Inc | Inhibiteurs sélectifs de la protéine arginine méthyltransférase 5 (prmt5) |
| EP3700906A1 (en) | 2017-10-26 | 2020-09-02 | Prelude Therapeutics, Incorporated | Selective inhibitors of protein arginine methyltransferase 5 (prmt5) |
| CA3092357A1 (en) * | 2018-03-14 | 2019-09-19 | Prelude Therapeutics, Incorporated | Selective inhibitors of protein arginine methyltransferase 5 (prmt5) |
-
2020
- 2020-04-03 WO PCT/US2020/026639 patent/WO2020206299A1/en not_active Ceased
- 2020-04-03 JP JP2021559255A patent/JP2022526604A/ja active Pending
- 2020-04-03 EP EP20785172.6A patent/EP3946352B1/en active Active
- 2020-04-03 US US17/601,485 patent/US12440506B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6464384B2 (ja) | キナーゼ阻害剤 | |
| JP2018070614A5 (enExample) | ||
| ES2260036T3 (es) | Derivados de urea como inhibidores del receptor ccr-3. | |
| JP2022505525A5 (enExample) | ||
| JP2012530703A5 (enExample) | ||
| JP2013517264A (ja) | 新規抗マラリア剤 | |
| TW200911232A (en) | Novel therapeutic compounds | |
| CA2895426A1 (en) | Bet-protein-inhibiting dihydroquinoxalinones | |
| JPH07504201A (ja) | 環式ａｍｐホスホジエステラーゼ及び腫瘍壊死因子の阻害剤としての１−アルコキシ−（２−アルコキシ−またはシクロアルコキシ）−４−（シクロチオアルキル−またはシクロチオアルケニル）ベンゼン | |
| WO2015066241A1 (en) | 2-benzyl-benzimidazole complement factor b inhibitors and uses thereof | |
| JP2014528404A (ja) | ｐ３８ＭＡＰキナーゼ阻害剤としての１−ピラゾリル−３−（４−（（２−アニリノピリミジン−４−イル）オキシ）ナフタレン−１−イル）尿素 | |
| RU2012153164A (ru) | Производные мочевины и их терапевтическое применение при лечении, среди прочего, заболеваний дыхательного пути | |
| JP2021535174A5 (enExample) | ||
| RU2383541C2 (ru) | Ингибиторы mif | |
| JP2007523868A (ja) | ウイルス複製の阻害薬として有用な置換アリールチオウレア誘導体類 | |
| JP2006512339A5 (enExample) | ||
| PT1942108E (pt) | Composto com um grupo básico e a sua utilização | |
| AU2017257755B2 (en) | Benzoylglycine derivatives and methods of making and using same | |
| JP2024532303A (ja) | 神経炎症性障害の治療 | |
| JP5833143B2 (ja) | フェニル−イソオキサゾール誘導体およびその製造方法 | |
| JPH11506772A (ja) | 抗ウイルス化合物 | |
| JPS63502179A (ja) | 新規なアリ−ル誘導体類 | |
| JP2018515527A (ja) | インフルエンザウイルスの複製の阻害剤 | |
| CN113767090A (zh) | 三环化合物及其制备方法和医药用途 | |
| JP2014502980A (ja) | 勃起不全治療用のピラゾロピリミドン化合物 |